| abstract |
Substituted benzenesulfonylureas and -thiomocities have an effect on the autonomic nervous system. The present invention relates to the use of said compounds in the treatment and prophylaxis of dysfunctions of the autonomic nervous system, particularly vagal dysfunctions, for example in the case of cardiovascular diseases, and their use for the preparation of medicaments for such treatment and prophylaxis. Further, the invention relates to the use of said compounds in combination with beta-receptor blockers and pharmaceutical compositions. |